Better results through less stress
Researchers in Hannover have developed a new method for studying neuroinfections. This reduces errors in analysis and delivers more accurate results.
Read moreAt TWINCORE, we combine the expertise of medical professionals and scientists from a wide range of disciplines to find answers to the pressing questions in infection research. Our focus: translational research – the bridge between basic science and clinical application.
Registration for the Lower Saxony International Summer Academy 2025 is open until 2025.
Find more information here!
Researchers in Hannover have developed a new method for studying neuroinfections. This reduces errors in analysis and delivers more accurate results.
Read moreA research team at TWINCORE was able to establish that TLR8 influences the formation of disease-relevant cytokines.
Read moreTWINCORE researchers show role of epistatic interaction in the omicron variant of SARS-CoV-2 virus .
Read moreWe conduct translational infection research to improve the prevention, diagnosis and treatment of infectious diseases in humans. We focus on three areas that characterize our research work. Find out here how we proceed and what results we achieve.
Under the leadership of our best scientists, various labs are working on different projects within our research topics.
C Lauber, X Zhang, J Vaas, F Klingler, P Mutz, A Dubin, T Pietschmann, O Roth, B W Neuman, A E Gorbalenya, R Bartenschlager, S Seitz
M B Krueger, A Bonifacius, A C Dragon, M M Santamorena, B Nashan, R Taubert, U Kalinke, B Maecker-Kolhoff, R Blasczyk, B Eiz-Vesper
M Bruhn, M Obara, A Salam, B Costa, A Ziegler, I Waltl, A Pavlou, M Hoffmann, T Graalmann, S Pöhlmann, A Schambach, U Kalinke
Patients with chronic rheumatic diseases have an increased risk of infection due to severe inflammation. This project investigates inflammation in various tissues, particularly in systemic sclerosis, in order to develop targeted therapies.
Immunomodulatory drugs for rheumatic diseases specifically influence immune cells and messenger substances. This project investigates their effect on immune responses in order to find individually suitable therapies.
Immunomodulatory drugs can have systemic side effects. This project is testing nanocarriers that deliver drugs specifically into myeloid immune cells in order to reduce side effects and increase the local effect.
The project investigates how HCMV is recognized by the immune system and which mechanisms the virus uses to camouflage itself. The aim is to understand the immune reactions and develop therapies for severely affected patients.
There are currently no events.